Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05807347
Status:
RECRUITING
Last Update Posted:
2023-04-11
First Post:
2023-02-27
Brief Title:
Venetoclax Combined With Azacitidine and CAG in RefractoryRelapse Acute Myeloid Leukemia
Sponsor:
Hematology department of the 920th hospital
Organization:
Hematology department of the 920th hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-27
First Submit QC Date:
March 28 2023
Study First Post Date:
2023-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-28
Last Update Post Date:
2023-04-11
Last Update Post Date Type:
ACTUAL